Mindset Pharma, Inc. is a pharmaceutical discovery and development company. It utilizes a proprietary platform for discovering novel and patentable psychedelic drug candidates for the treatment of neurological and psychiatric disorders. The company was founded by Abdelmalik Slassi on October 7, 2019 and is headquartered in Toronto, Canada.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company